Drug recall · April 8, 2020
Fentanyl Citrate Injection recall
Why: Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02
- Lots / codes
Lot 081887A, EXP 08/2021
- Quantity
- 15,170 ampules
- Company
- Akorn Inc, Lake Forest, IL
- Distribution
- Distributed Nationwide in the USA
- Initiated
- March 25, 2020 · Voluntary: Firm initiated
- Classified
- May 1, 2020
- Reported
- April 8, 2020
- Ended
- July 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fentanyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.